Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial) Article Swipe

View

Johanna Falkenhorst , Philipp Ivanyi , Tom Schulz , Rainer Hamacher , Bernd Kasper , Peter Hohenberger , Christoph K.W. Deinzer , Daniel Pink , Benjamin S. Fletcher , Valerie Haller , Yasmin Optaczy , Susanne Grünewald , Daniel Rauh , Adrián Mariño‐Enríquez , Thomas Mühlenberg , Peter Reichardt , Sebastian Bauer ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.30255136

Structural Analyses of sunitinib, regorafenib and ripretinib in T670I-mutant KIT

Related Topics

Truth And Reconciliation Commission Of Canada

2025 Nba Draft

28 Years Later

Concepts

No concepts available.

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.30255136
OA Status: gold
OpenAlex ID: https://openalex.org/W4414747014

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4414747014

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.30255136

Digital Object Identifier
Title: Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-10-01

Full publication date if available
Authors: Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz, Rainer Hamacher, Bernd Kasper, Peter Hohenberger, Christoph K.W. Deinzer, Daniel Pink, Benjamin S. Fletcher, Valerie Haller, Yasmin Optaczy, Susanne Grünewald, Daniel Rauh, Adrián Mariño‐Enríquez, Thomas Mühlenberg, Peter Reichardt, Sebastian Bauer

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.30255136

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.30255136

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex

Full payload

id	https://openalex.org/W4414747014
doi	https://doi.org/10.1158/1078-0432.30255136
ids.doi	https://doi.org/10.1158/1078-0432.30255136
ids.openalex	https://openalex.org/W4414747014
fwci	0.0
type	article
title	Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11485
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.996999979019165
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2715
topics[0].subfield.display_name	Gastroenterology
topics[0].display_name	Gastrointestinal Tumor Research and Treatment
topics[1].id	https://openalex.org/T11215
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9487000107765198
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2720
topics[1].subfield.display_name	Hematology
topics[1].display_name	Chronic Myeloid Leukemia Treatments
topics[2].id	https://openalex.org/T10696
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9248999953269958
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2740
topics[2].subfield.display_name	Pulmonary and Respiratory Medicine
topics[2].display_name	Gastric Cancer Management and Outcomes
is_xpac	False
apc_list
apc_paid
language	en
locations[0].id	doi:10.1158/1078-0432.30255136
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.30255136
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5065698112
authorships[0].author.orcid	https://orcid.org/0000-0002-4738-7121
authorships[0].author.display_name	Johanna Falkenhorst
authorships[0].author_position	first
authorships[0].raw_author_name	Johanna Falkenhorst
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5026803534
authorships[1].author.orcid	https://orcid.org/0000-0002-2862-7302
authorships[1].author.display_name	Philipp Ivanyi
authorships[1].author_position	middle
authorships[1].raw_author_name	Philipp Ivanyi
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5002272267
authorships[2].author.orcid	https://orcid.org/0000-0003-4070-7791
authorships[2].author.display_name	Tom Schulz
authorships[2].author_position	middle
authorships[2].raw_author_name	Tom Schulz
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5078401150
authorships[3].author.orcid	https://orcid.org/0000-0001-9655-1226
authorships[3].author.display_name	Rainer Hamacher
authorships[3].author_position	middle
authorships[3].raw_author_name	Rainer Hamacher
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5076043217
authorships[4].author.orcid	https://orcid.org/0000-0001-8425-8356
authorships[4].author.display_name	Bernd Kasper
authorships[4].author_position	middle
authorships[4].raw_author_name	Bernd Kasper
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5046601855
authorships[5].author.orcid	https://orcid.org/0000-0001-5359-5923
authorships[5].author.display_name	Peter Hohenberger
authorships[5].author_position	middle
authorships[5].raw_author_name	Peter Hohenberger
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5021671231
authorships[6].author.orcid	https://orcid.org/0009-0006-1961-9382
authorships[6].author.display_name	Christoph K.W. Deinzer
authorships[6].author_position	middle
authorships[6].raw_author_name	Christoph K.W. Deinzer
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5038723818
authorships[7].author.orcid	https://orcid.org/0000-0001-7243-7373
authorships[7].author.display_name	Daniel Pink
authorships[7].author_position	middle
authorships[7].raw_author_name	Daniel Pink
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5048279582
authorships[8].author.orcid	https://orcid.org/0009-0000-9986-5677
authorships[8].author.display_name	Benjamin S. Fletcher
authorships[8].author_position	middle
authorships[8].raw_author_name	Benjamin S. Fletcher
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5038823452
authorships[9].author.orcid
authorships[9].author.display_name	Valerie Haller
authorships[9].author_position	middle
authorships[9].raw_author_name	Valerie Haller
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5093551541
authorships[10].author.orcid	https://orcid.org/0009-0005-7543-5492
authorships[10].author.display_name	Yasmin Optaczy
authorships[10].author_position	middle
authorships[10].raw_author_name	Yasmin Optaczy
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5113583584
authorships[11].author.orcid
authorships[11].author.display_name	Susanne Grünewald
authorships[11].author_position	middle
authorships[11].raw_author_name	Susanne Grunewald
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5071830380
authorships[12].author.orcid	https://orcid.org/0000-0002-1970-7642
authorships[12].author.display_name	Daniel Rauh
authorships[12].author_position	middle
authorships[12].raw_author_name	Daniel Rauh
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5035089484
authorships[13].author.orcid	https://orcid.org/0000-0002-7680-9901
authorships[13].author.display_name	Adrián Mariño‐Enríquez
authorships[13].author_position	middle
authorships[13].raw_author_name	Adrian Mariño-Enríquez
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5065352177
authorships[14].author.orcid	https://orcid.org/0000-0002-2078-8857
authorships[14].author.display_name	Thomas Mühlenberg
authorships[14].author_position	middle
authorships[14].raw_author_name	Thomas Mühlenberg
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5048170384
authorships[15].author.orcid	https://orcid.org/0009-0008-1410-3111
authorships[15].author.display_name	Peter Reichardt
authorships[15].author_position	middle
authorships[15].raw_author_name	Peter Reichardt
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5031540987
authorships[16].author.orcid	https://orcid.org/0000-0001-5949-8120
authorships[16].author.display_name	Sebastian Bauer
authorships[16].author_position	last
authorships[16].raw_author_name	Sebastian Bauer
authorships[16].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.30255136
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11485
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.996999979019165
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2715
primary_topic.subfield.display_name	Gastroenterology
primary_topic.display_name	Gastrointestinal Tumor Research and Treatment
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.30255136
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.30255136
primary_location.id	doi:10.1158/1078-0432.30255136
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.30255136
publication_date	2025-10-01
publication_year	2025
referenced_works_count	0
abstract_inverted_index.in	7
abstract_inverted_index.of	2
abstract_inverted_index.and	5
abstract_inverted_index.Analyses	1
abstract_inverted_index.ripretinib	6
abstract_inverted_index.sunitinib,	3
abstract_inverted_index.regorafenib	4
abstract_inverted_index.T670I-mutant	8
abstract_inverted_index.KIT</p>	9
abstract_inverted_index.<p>Structural	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	17
citation_normalized_percentile.value	0.63155363
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False